Cite

HARVARD Citation

    Lam, C. et al. (n.d.). OC-069 Mesalazine For Treatment Of Diarrhoea-predominant Irritable Bowel Syndrome (ibs-d): A Multi-centre, Parallel Group, Randomised Placebo Controlled Trial. Gut. p. A34. [Online]. 
  
Back to record